Palisade Bio, Inc. · NASDAQ:PALI
Finley John David sold 146,798 Palisade Bio, Inc. shares (Form 4)
Traded Jul 6 to Jul 7, 2026 · Filed Jul 8, 2026
From Jul 6 to Jul 7, 2026, Finley John David (Director, CEO, CFO) sold 146,798 Palisade Bio, Inc. shares at US$2.07 for US$304K, leaving 217,688 shares. Filed Jul 8, 2026 (Form 4).
- Sold
- 146,798 shares
- Price
- US$2.07
- Value
- US$304K
- Holding after
- 217,688 shares
- Trading plan
- No
- Role
- Director, CEO, CFO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | Common Stock | Option exercise | 335,167 | 364,353 | Direct | |
| Jul 7, 2026 | Common Stock | Sale | 146,798 | US$2.07 | 217,555 | Direct |
| Jul 7, 2026 | Common Stock | Option exercise | 133 | US$0.70 | 217,688 | Direct |
Source
Related
- Palisade Bio, Inc.
- Finley John David
- Palisade Bio, Inc. shareholders
- Form 4 · Finley John David · Oct 7, 2026
- Form 4 · Finley John David · Aug 21, 2026
- Form 4 · Jones Mitchell Lawrence · Oct 7, 2026
- Form 4 · Williams Donald Allen · Oct 5, 2026
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Aug 13, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026